HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease The largest prospective registry of its kind will build upon clinical data supporting the use of plaque insights to empower clinical decision making for patients with suspected coronary artery disease MOUNTAIN VIEW, Calif. – March 26, […]
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography HeartFlow’s non-invasive AI driven FFRCT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif. – March 12, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart […]
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT Category I CPT code for Fractional Flow Reserve derived from Computed Tomography will provide broader access to HeartFlow’s AI-powered technology, a standard of care for evaluating and treating coronary artery disease MOUNTAIN VIEW, Calif. – January 23, 2024 — HeartFlow, Inc., a leader in non-invasive […]
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease with FFRCT Analysis
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis This patient milestone and the recent launch of Plaque Analysis and RoadMapTM Analysis further solidify HeartFlow as a pioneer in AI-enabled CAD diagnostics MOUNTAIN VIEW, Calif. – January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) […]
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights New Clinical Data Support Use of Lesion-Specific FFRCT for Diagnosis and Treatment of Patients With Coronary Artery Disease MOUNTAIN VIEW, Calif. – October 25, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care solutions, today announced results from […]
Recent Study from England’s National Health Service Highlights Positive Impact of Implementing HeartFlow’s FFRCT Analysis for Diagnosis of Coronary Artery Disease
Recent Study from England’s National Health Service Highlights Positive Impact of Implementing HeartFlow’s FFRCT Analysis for Diagnosis of Coronary Artery Disease Significant reduction in cardiovascular mortality and all-cause mortality for CCTA coupled with FFRCT versus CCTA alone MOUNTAIN VIEW, Calif. – August 26, 2023 —Two-year results from FISH&CHIPS, a real world, multi-center, retrospective clinical study […]
New Data from Clinical Studies Further Validate HeartFlow’s All-in-One Portfolio of Precision Coronary Care Solutions
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making MOUNTAIN VIEW, Calif. – July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy, utility, and efficiency of HeartFlow’s portfolio of coronary computed tomography angiography (CCTA)-based […]
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting MOUNTAIN VIEW, Calif. – July 24, 2023 — HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, today announced that new data on […]
New HeartFlow RoadMap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings
Press Release New HeartFlow RoadMap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings Non-invasive, AI-enabled product helps CT readers to accurately*, efficiently, and consistently identify narrowings in the coronary arteries, advancing the HeartFlow portfolio MOUNTAIN VIEW, Calif. – April 17, 2023 — HeartFlow, Inc. today announced the launch of the […]
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences
Financing will further drive commercial scale for HeartFlow’s AI-enabled portfolio of precision heart care products MOUNTAIN VIEW, Calif. – April 6, 2023 — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million Series F funding round by its parent company, HeartFlow Holding, Inc. led by Bain Capital Life […]
